<DOC>
	<DOCNO>NCT01657292</DOCNO>
	<brief_summary>The main goal phase III clinical trial show safety efficacy Oleogel-S10 acceleration wound heal grade 2a burn wound .</brief_summary>
	<brief_title>Oleogel-S10 Versus Standard Care Healing Grade 2a Burn Wounds</brief_title>
	<detailed_description>Oleogel-S10 show efficacy well tolerate previous clinical trial patient skin lesion . Especially result split-thickness skin graft donor site , regard excellent model kind superficial wound human skin , suggest Oleogel-S10 efficacious safe treatment grade 2a burn . The present Phase III clinical trial grade 2a burn initiate order measure wound heal progress apply objective method , i.e. , time heal grade epithelialization wound . In study , grade 2a burn wound separate two half : Following wound clean disinfection , wound separate two wound half . Randomly assign , one wound half receive Oleogel-S10 ointment , wound half standard care treatment . Wound heal progress document photo assess expert reviewer blind treatment wound half .</detailed_description>
	<mesh_term>Burns</mesh_term>
	<criteria>Patients least 18 year old provide write informed consent . Presenting acute grade 2a burn wound ( grade expert surgeon assist LDI multispectral imaging system ) within 48 hour injury . Burn wound cause fire burn , heat burn scald . Burn patient grade 2a burn wound 80 cm2 less 25 % TBSA ( alternatively , 2 comparable wound size 40 cm2 less 12.5 % TBSA allow ) . Patient able understand Informed Consent Form provide prepared comply study requirement , include follow : Visiting trial site wound dress change least every second day ( patient hospitalize ) photo documentation full wound closure Investigator decide change medication and/or treatment day 21 start treatment Willing perform necessary wound dress change trial site . Also patient need agree return site 3 12 month followup visit . Women childbearing potential must apply highly effective method birth control ( failure rate le 1 % per year use consistently correctly ( e.g. , implant , injectables , combine oral contraceptive , intrauterine contraceptive device ( IUDs ) , sexual abstinence , vasectomized partner ) ) Suffering chemical burn , electrical burn sunburn Having already receive treatment burn silver sulfadiazine ( obscure photographic wound evaluation ) . Positive blood culture burn . Diseases condition could , opinion Investigator , interfere assessment safety , tolerance efficacy . A skin disorder chronic currently active Investigator considers adversely affect heal acute wound involve area examine trial . A history clinically significant hypersensitivity drug surgical dressing use trial . Known multiple allergic disorder . Taking , take , investigational drug within 3 month prior screen visit . Pregnant breast feed woman allow participate study . Inappropriate participate study , reason , opinion Investigator . Mental incapacity language barrier preclude adequate understanding cooperation willingness follow study procedure . Previous participation study . Employee investigational site , relative spouse Investigator</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>Wound heal</keyword>
	<keyword>Burn wound</keyword>
	<keyword>Superficial partial-thickness burn wound</keyword>
	<keyword>Grade 2a burn wound</keyword>
	<keyword>Time wound closure</keyword>
</DOC>